New recommendations to guide dermatologic surgery during the COVID-19 pandemic are heavy on the deferral of skin cancer excisions including all BCCs, SCC-in-situ and melanoma-in-situ. The advice, published in the Journal of the American Academy of Dermatology (JAAD), suggests deferring superficial BCCs for six months and other BCCs for 3-6 months. Actinic keratosis and SCC-in-situ ...
New advice to defer skin cancer surgery because of COVID-19
By Mardi Chapman
17 Apr 2020